Drugs Xagena
Investigational once-daily oral, direct factor Xa inhibitor, Edoxaban ( Lixiana ), was shown to be superior to Enoxaparin ( Lovenox ) in preventing venous thromboembolic ( VTE ) events in patients fol ...
Edoxaban ( Lixiana, Savaysa ) is an oral factor Xa ( FXa ) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives ...
Warfarin ( Coumadin ) is the most widely used oral anticoagulant worldwide, but serious bleeding complications are common. Researchers have tested whether genetic variants can identify patients who ...
The European Committee for Medicinal Products for Human Use ( CHMP ) has recommended approval of Lixiana ( Edoxaban ), an oral, once-daily selective factor Xa inhibitor, for the prevention of stroke a ...
